DEPARTMENT OF

Policy Analysis and Management

Working Papers

 
 
Working Papers for the Consumers, Pharmaceutical Policy, and Health Program
  1. Medicare Part D’s Effects on Elderly Patients’ Drug Costs and Utilization, The American Journal of Managed Care,   Volume 14:SP14-SP21 November 2008. [abstract & pdf]
    Ketcham, J., Simon, K.
  2. How Oncologists Learn About New Chemotherapy Drugs
    LeCates, J., Lucarelli, C., Nicholson, S.
  3. Measuring Welfare and the Effects of Regulation in a Government-Created Market: The Case of Medicare Part D Plans
    Lucarelli, C., Prince, J., and Simon, K.
  4. Health Disparities and Direct-to-Consumer Advertising of Pharmaceutical Products.
    Avery, R., Kenkel, D., Lillard, D.R., Mathios, A., and Wang, H.
  5. The Impact of Direct-to-Consumer Advertising of Cholesterol Reducing Drugs on Diagnosis and Treatment of Cholesterol.
    Yang, H-K., Mathios, A., Avery, R.
  6. A Quality-Adjusted Price Index for Colorectal Cancer.
    Lucarelli, C., Nicholson, S.
  7. What Policies are States Using to Control Medicaid Prescription Drug Spending during 1990-2004, and How Effective are They?
    Simon, K., Tennyson, S., Hudman, J.
  8. Young Adult Exposure to Smoking Cessation Product Advertising
    Avery, R., Kenkel, D., Lillard, D.R., and Mathios, A.
  9. What Drove First Year Premiums in Stand-Alone Medicare Drug Plans?
    Simon, K., and Lucarelli, C.
  10. Private Profits and Public Health: Does Advertising of Smoking Cessation Products Encourage Smokers to Quit?
    Avery, R., Kenkel, D., Lillard, D.R., and Mathios, A.
  11. Trends in State Medicaid Prescription Drug Policies 1990-2004: What are the Main Policy Tools States are Using?
    Tennyson, S., Simon, K., Hudman, J.
  12. Generic Scrip Share and the Price of Brand-name Drugs:The Role of Consumer Choice
    Rizzo, J., and Zeckhauser, R.
  13. The Competitive Effects of Drug Withdrawals: The Case of Fen-Phen
    Cawley, J., and Rizzo, J.
  14. Regulating Advertisements: The Case of Smoking Cessation Products
    Avery, R. J., Kenkel, D. M., Lillard, D., and Mathios, A. D.
  15. One Pill Makes You Smaller: The Utilization of Anti-Obesity Drugs
    Cawley, J., and Rizzo, J.
  16. Evidence of a Return on Investment (ROI) from Selected Disease Management Programs: A Review of the Literature
    Goetzel, R. Z., Ozminkowski, R. J., Villagra, V. G., and Duffy, J.
  17. Income and the Use of Prescription Drugs by the Elderly: Evidence from the Notch Cohorts
    Moran, J., and Simon,K.
  18. Explaining Variation in Physician Practice Patterns and their Propensities To Recommend Services
    O'Neill, L., and Kuder, J. (Abstract)
  19. Consumer Demand for Pharmaceuticals: Heuristics or Rational Choice?
    Rizzo, J.